Swine Vaccine Market Insights and Updates by 2031
The Swine Vaccine Market is expected to register a CAGR of 5.0% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Swine Vaccine Market By Product (Recombinant, Inactivated); Type (Pseudorabies, Porcine Circovirus Type 2), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Swine Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Swine Vaccine Market Segmentation
By Product- Recombinant
- Inactivated
- Pseudorabies
- Porcine Circovirus Type 2
Strategic Insights
Swine Vaccine Market Growth Drivers- Rising Prevalence of Swine Diseases: For swine breeders, diseases including Porcine Circovirus Type 2 (PCV2), African Swine Fever (ASF), and Porcine Reproductive and Respiratory Syndrome (PRRS) are serious issues. Farmers must implement immunization programs due to the rising prevalence of these illnesses in order to stop outbreaks and financial losses.
- Technological Advancements: The safety and effectiveness of swine vaccines are improved by advancements in vaccine development, such as recombinant and DNA vaccines. These developments increase vaccines' attractiveness to manufacturers, which propels market expansion. Since outbreaks have a negative economic impact on the agriculture industry, several governments are pushing vaccination campaigns to prevent swine illnesses. Market expansion is further supported by funding and assistance for vaccination technology research and development.
- Increased Awareness and Demand for Animal Health: Farmers are adopting vaccination procedures more frequently as a result of their increased focus on the health and wellbeing of their animals. Increased customer demand for safe and healthful pork products supports this trend. DNA vaccines, recombinant vaccines, and inactivated vaccines make up the market segments. Since inactivated vaccines are more stable and have a reduced chance of side effects than live-attenuated vaccinations, they are predicted to take the lead.
- Funding and Research Support: Governments frequently set aside money to aid in the study and creation of novel vaccinations. For example, the National Institute of Food and Agriculture (NIFA) of the USDA has awarded large funding to organizations such as Cornell University to produce swine influenza vaccines, which directly advances vaccine availability and technology.
- Collaborative Research Initiatives: Innovative vaccine development is facilitated by collaborations between public and private sectors. For instance, the Foundation for Food & Agriculture Research has provided funding for initiatives to develop vaccines against highly contagious illnesses like African Swine Fever (ASF), underscoring the significance of government engagement in addressing new health risks.
- Preventive Health Initiatives: Governments run vaccination campaigns as part of their strategies to manage swine illnesses. As an illustration of the preventive steps taken to protect the pig industry from possible outbreaks, Canada started a USD 23.4 million program to prepare for ASF.
- Awareness Campaigns: Access to ocular prostheses is improved in developing nations due to advancements in healthcare infrastructure and increased disposable income. Because of their sizable populations and rising knowledge of eye care products, nations like China and India offer substantial growth prospects.
- Increased Market Competition: Government-led educational programs aid in educating farmers about the advantages of vaccination. By encouraging producers to take preventative action, these efforts raise the demand for swine vaccines generally.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Regulatory Frameworks: Before vaccinations are put on the market, government authorities make sure they meet safety and effectiveness standards. This governmental oversight encourages farmers to use these goods without fear and increases customer faith in immunization programs. To reduce the danger of disease transmission, governments support vaccination programs in conjunction with biosecurity measures. The economic stability of the swine business depends on the productivity and health of the herd, which can only be maintained with this integrated approach.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Swine Vaccine Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Swine Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
High Competition and Price Pressure
Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period
Asia Pacific region is expected to witness the highest growth during the forecast period
Rising Prevalence of Swine Diseases
The Swine Vaccine Market is estimated to witness a CAGR of 5.0% from 2023 to 2031
Awareness Campaigns
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Swine Vaccine Market - By Product
1.3.2 Swine Vaccine Market - By Type
1.3.3 Swine Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SWINE VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SWINE VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SWINE VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. SWINE VACCINE - GLOBAL MARKET OVERVIEW
6.2. SWINE VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SWINE VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT
7.3.1. Overview
7.3.2. Recombinant Market Forecast and Analysis
7.4. INACTIVATED
7.4.1. Overview
7.4.2. Inactivated Market Forecast and Analysis
8. SWINE VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. PSEUDORABIES
8.3.1. Overview
8.3.2. Pseudorabies Market Forecast and Analysis
8.4. PORCINE CIRCOVIRUS TYPE 2
8.4.1. Overview
8.4.2. Porcine Circovirus Type 2 Market Forecast and Analysis
9. SWINE VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Swine Vaccine Market Overview
9.1.2 North America Swine Vaccine Market Forecasts and Analysis
9.1.3 North America Swine Vaccine Market Forecasts and Analysis - By Product
9.1.4 North America Swine Vaccine Market Forecasts and Analysis - By Type
9.1.5 North America Swine Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Swine Vaccine Market
9.1.5.1.1 United States Swine Vaccine Market by Product
9.1.5.1.2 United States Swine Vaccine Market by Type
9.1.5.2 Canada Swine Vaccine Market
9.1.5.2.1 Canada Swine Vaccine Market by Product
9.1.5.2.2 Canada Swine Vaccine Market by Type
9.1.5.3 Mexico Swine Vaccine Market
9.1.5.3.1 Mexico Swine Vaccine Market by Product
9.1.5.3.2 Mexico Swine Vaccine Market by Type
9.2. EUROPE
9.2.1 Europe Swine Vaccine Market Overview
9.2.2 Europe Swine Vaccine Market Forecasts and Analysis
9.2.3 Europe Swine Vaccine Market Forecasts and Analysis - By Product
9.2.4 Europe Swine Vaccine Market Forecasts and Analysis - By Type
9.2.5 Europe Swine Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Swine Vaccine Market
9.2.5.1.1 Germany Swine Vaccine Market by Product
9.2.5.1.2 Germany Swine Vaccine Market by Type
9.2.5.2 France Swine Vaccine Market
9.2.5.2.1 France Swine Vaccine Market by Product
9.2.5.2.2 France Swine Vaccine Market by Type
9.2.5.3 Italy Swine Vaccine Market
9.2.5.3.1 Italy Swine Vaccine Market by Product
9.2.5.3.2 Italy Swine Vaccine Market by Type
9.2.5.4 Spain Swine Vaccine Market
9.2.5.4.1 Spain Swine Vaccine Market by Product
9.2.5.4.2 Spain Swine Vaccine Market by Type
9.2.5.5 United Kingdom Swine Vaccine Market
9.2.5.5.1 United Kingdom Swine Vaccine Market by Product
9.2.5.5.2 United Kingdom Swine Vaccine Market by Type
9.2.5.6 Rest of Europe Swine Vaccine Market
9.2.5.6.1 Rest of Europe Swine Vaccine Market by Product
9.2.5.6.2 Rest of Europe Swine Vaccine Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Swine Vaccine Market Overview
9.3.2 Asia-Pacific Swine Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Swine Vaccine Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Swine Vaccine Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Swine Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Swine Vaccine Market
9.3.5.1.1 Australia Swine Vaccine Market by Product
9.3.5.1.2 Australia Swine Vaccine Market by Type
9.3.5.2 China Swine Vaccine Market
9.3.5.2.1 China Swine Vaccine Market by Product
9.3.5.2.2 China Swine Vaccine Market by Type
9.3.5.3 India Swine Vaccine Market
9.3.5.3.1 India Swine Vaccine Market by Product
9.3.5.3.2 India Swine Vaccine Market by Type
9.3.5.4 Japan Swine Vaccine Market
9.3.5.4.1 Japan Swine Vaccine Market by Product
9.3.5.4.2 Japan Swine Vaccine Market by Type
9.3.5.5 South Korea Swine Vaccine Market
9.3.5.5.1 South Korea Swine Vaccine Market by Product
9.3.5.5.2 South Korea Swine Vaccine Market by Type
9.3.5.6 Rest of Asia-Pacific Swine Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Swine Vaccine Market by Product
9.3.5.6.2 Rest of Asia-Pacific Swine Vaccine Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Swine Vaccine Market Overview
9.4.2 Middle East and Africa Swine Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Swine Vaccine Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Swine Vaccine Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Swine Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Swine Vaccine Market
9.4.5.1.1 South Africa Swine Vaccine Market by Product
9.4.5.1.2 South Africa Swine Vaccine Market by Type
9.4.5.2 Saudi Arabia Swine Vaccine Market
9.4.5.2.1 Saudi Arabia Swine Vaccine Market by Product
9.4.5.2.2 Saudi Arabia Swine Vaccine Market by Type
9.4.5.3 U.A.E Swine Vaccine Market
9.4.5.3.1 U.A.E Swine Vaccine Market by Product
9.4.5.3.2 U.A.E Swine Vaccine Market by Type
9.4.5.4 Rest of Middle East and Africa Swine Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Swine Vaccine Market by Product
9.4.5.4.2 Rest of Middle East and Africa Swine Vaccine Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Swine Vaccine Market Overview
9.5.2 South and Central America Swine Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Swine Vaccine Market Forecasts and Analysis - By Product
9.5.4 South and Central America Swine Vaccine Market Forecasts and Analysis - By Type
9.5.5 South and Central America Swine Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Swine Vaccine Market
9.5.5.1.1 Brazil Swine Vaccine Market by Product
9.5.5.1.2 Brazil Swine Vaccine Market by Type
9.5.5.2 Argentina Swine Vaccine Market
9.5.5.2.1 Argentina Swine Vaccine Market by Product
9.5.5.2.2 Argentina Swine Vaccine Market by Type
9.5.5.3 Rest of South and Central America Swine Vaccine Market
9.5.5.3.1 Rest of South and Central America Swine Vaccine Market by Product
9.5.5.3.2 Rest of South and Central America Swine Vaccine Market by Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SWINE VACCINE MARKET, KEY COMPANY PROFILES
11.1. ZOETIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELANCO
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. INDIAN IMMUNOLOGICALS LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOGéNESISBAGó
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PHIBRO ANIMAL HEALTH
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. KM BIOLOGICS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HIPRA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK ANIMAL HEALTH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CEVA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Zoetis
2.Boehringer Ingelheim GmbH
3.Elanco
4.Indian Immunologicals Ltd.
5.BiogénesisBagó
6.Phibro Animal Health
7.KM Biologics
8.HIPRA
9.Merck Animal Health
10.Ceva
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For